![Alex Rothwell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alex Rothwell
Director of Finance/CFO at
EUPRAXIA PHARMACEUTICALS INC.
Net worth: 7 M $ as of 2026-08-30
Profile
Alex Rothwell is Chief Financial Officer at Eupraxia Pharmaceuticals, Inc. since 2025.
Former roles include Independent Director at Alset AI Ventures, Inc. from 2017 to 2018, Senior Managing Partner at Orion Securities, Inc., and Head of Canadian Equities at Macquarie Capital Markets Canada Ltd. Education includes an undergraduate degree from McGill University in 1991 and an MBA from Richard Ivey School of Business in 1995.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-14 | 1,104,000 ( 1.69% ) | 7 M $ | 2026-08-30 |
Alex Rothwell active positions
| Companies | Position | Start |
|---|---|---|
| EUPRAXIA PHARMACEUTICALS INC. | Director of Finance/CFO | 2025-02-17 |
Former positions of Alex Rothwell
| Companies | Position | End |
|---|---|---|
| ALSET AI VENTURES INC. | Director/Board Member | 2018-12-09 |
Orion Securities, Inc.
 Orion Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Macquarie Capital Markets Canada Ltd.
 Macquarie Capital Markets Canada Ltd. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Training of Alex Rothwell
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Alset AI Ventures, Inc.
 Alset AI Ventures, Inc. Information Technology ServicesTechnology Services Provides investment services | Technology Services |
Eupraxia Pharmaceuticals, Inc.
 Eupraxia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company focused on the development of delivered, extended-release alternatives to currently approved drugs | Health Technology |
Orion Securities, Inc.
Orion Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Macquarie Capital Markets Canada Ltd.
Macquarie Capital Markets Canada Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Richard Ivey School of Business
 Richard Ivey School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Alex Rothwell
